Key facts
- GalenusCare’s last known valuation is $20.9M (Feb 2026).
- It has raised $5.4M; the latest was Seed Round ($5.4M) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for GalenusCare
- ·The full record, as it builds
Funding rounds
No funding rounds for GalenusCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GalenusCare
Operator of a precision pharmacy services intended to serve hospice and chronic care, based in New Jersey. The company provides pharmacist led AI supported medication regimen management, compliance packaging, symptom kits, and coordinated pharmacy operations to optimize medication safety, support interdisciplinary care teams, and lower healthcare utilization and medical costs, enabling healthcare teams to optimize medication outcomes and ensure patient safety.
- Sector
- Healthcare
- HQ
- Mount Laurel, NJ, United States
- Founded
- 2025
- Employees
- 11
- Website
- galenuscare.com/
- Ownership
- Privately Held (backing)
GalenusCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GalenusCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GalenusCare in its N-PORT filings yet. We sweep new filings monthly.